INSMED Inc (INSM)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Product revenues, net | 107,415 | 92,823 | 93,425 | 90,340 |
| Selling, general and administrative | - | - | 118,930 | 106,569 |
| Selling, general and administrative | 154,763 | 147,545 | - | - |
| Research and development | 177,190 | 152,577 | 150,809 | 146,748 |
| Cost of product revenues (excluding amortization of intangible assets) | 28,075 | 21,278 | 21,170 | 20,964 |
| Change in fair value of deferred and contingent consideration liabilities | 59,000 | 18,300 | 14,682 | 103,700 |
| Amortization of intangible assets | 1,263 | 1,263 | 1,263 | 1,263 |
| Total operating expenses | 420,291 | 340,963 | 306,854 | 379,244 |
| Operating loss | -312,876 | -248,140 | -213,429 | -288,904 |
| Investment income | 13,225 | 13,906 | 16,982 | 10,285 |
| Interest expense | 21,245 | 21,569 | 21,054 | 21,267 |
| Other income (expense), net | 453 | 132 | 1,843 | -269 |
| Change in fair value of interest rate swap | - | - | -3,852 | 384 |
| Loss before income taxes | -320,443 | -255,671 | -219,510 | -299,771 |
| Provision for income taxes | 1,243 | 912 | 1,014 | 838 |
| Net loss | -321,686 | -256,583 | -220,524 | -300,609 |
| Basic net loss per share (in dollars per share) | -1.7 | -1.42 | -1.27 | -1.94 |
| Diluted net loss per share (in dollars per share) | -1.7 | -1.42 | -1.27 | -1.94 |
| Weighted average basic common shares outstanding (in shares) | 189,302,000 | 180,860,000 | 173,721,000 | 154,702,000 |
| Weighted average diluted common shares outstanding (in shares) | 189,302,000 | 180,860,000 | 173,721,000 | 154,702,000 |